ACTRN12615000460505
终止
1 期
In people with treatment resistant schizophrenia, is sodium benzoate a tolerated and acceptable augmentation strategy: a phase Ib/II study.
niveristy of Otago0 个研究点目标入组 1 人2015年5月12日
概览
- 阶段
- 1 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Schizophrenia
- 发起方
- niveristy of Otago
- 入组人数
- 1
- 状态
- 终止
- 最后更新
- 5年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\.A clinical diagnosis of Schizophrenia, confirmed by a structured diagnostic interview.
- •2\.Have a body mass index between 18 and 35 (that is, not underweight or markedly overweight)
- •3\.Have had no major change in their symptoms for three months.
- •4\.Have moderate to severe current symptom
排除标准
- •1\.You are pregnant or are intending to become pregnant.
- •2\.Have a history of alcohol or drug dependance.
- •3\.Have a history of epilepsy, head injury, or a neurological disorder.
- •4\.If participating in the trial would place you at unacceptable risk.
- •5\.If you are considered highly likely to not take any medications, as part of the study or not.
结局指标
主要结局
未指定
相似试验
招募中
不适用
Therapie Resistentie Voorspellen bij SchizofrenieSchizophrenia, treatment resistance, psychosis, schizofrenie, therapie resistentie, psychoseNL-OMON21525Amsterdam UMC, University of Amsterdam100
已完成
不适用
Predicting Treatment Resistance in Schizophreniafirst episode psychosisschizophrenia10039628NL-OMON48828Academisch Medisch Centrum120
终止
3 期
Augmentation of antipsychotic medication with anticonvulsant in the management of treatment resistant schizophreniaSchizophreniaMental and Behavioural DisordersISRCTN77257074King's College London371
已完成
不适用
Assertive Outreach for people with schizophreniaDRKS00003351euphana Universität Lüneburg341
已完成
不适用
Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulatioISRCTN93378085Record Provided by the NHSTCT Register - 2007 Update - Department of Health12